Cell MedX Past Earnings Performance
Past criteria checks 0/6
Cell MedX has been growing earnings at an average annual rate of 20%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been declining at an average rate of 38.8% per year.
Key information
20.0%
Earnings growth rate
27.5%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | -38.8% |
| Return on equity | n/a |
| Net Margin | -130,962.2% |
| Last Earnings Update | 29 Feb 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Cell MedX makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 29 Feb 24 | 0 | 0 | 0 | 0 |
| 30 Nov 23 | 0 | 0 | 0 | 0 |
| 31 Aug 23 | 0 | 0 | 0 | 0 |
| 31 May 23 | 0 | 0 | 0 | 0 |
| 28 Feb 23 | 0 | -1 | 0 | 0 |
| 30 Nov 22 | 0 | -1 | 0 | 0 |
| 31 Aug 22 | 0 | -1 | 0 | 0 |
| 31 May 22 | 0 | -1 | 1 | 0 |
| 28 Feb 22 | 0 | -1 | 1 | 0 |
| 30 Nov 21 | 0 | -1 | 1 | 0 |
| 31 Aug 21 | 0 | -1 | 1 | 0 |
| 31 May 21 | 0 | -1 | 0 | 0 |
| 28 Feb 21 | 0 | -1 | 1 | 0 |
| 30 Nov 20 | 0 | -1 | 1 | 0 |
| 31 Aug 20 | 0 | -1 | 1 | 0 |
| 31 May 20 | 0 | -1 | 1 | 0 |
| 29 Feb 20 | 0 | -1 | 1 | 0 |
| 30 Nov 19 | 0 | -1 | 1 | 0 |
| 31 Aug 19 | 0 | -1 | 1 | 0 |
| 31 May 19 | 0 | -1 | 0 | 0 |
| 28 Feb 19 | 0 | -1 | 0 | 0 |
| 30 Nov 18 | 0 | -1 | 0 | 1 |
| 31 Aug 18 | 0 | -1 | 0 | 1 |
| 31 May 18 | 0 | -2 | 1 | 0 |
| 28 Feb 18 | 0 | -1 | 1 | 0 |
| 30 Nov 17 | 0 | -1 | 1 | 0 |
| 31 Aug 17 | 0 | -2 | 1 | 0 |
| 31 May 17 | 0 | -1 | 1 | 0 |
| 28 Feb 17 | 0 | -2 | 1 | 0 |
| 30 Nov 16 | 0 | -2 | 1 | 0 |
| 31 Aug 16 | 0 | -1 | 1 | 0 |
| 31 May 16 | 0 | -2 | 1 | 1 |
| 29 Feb 16 | 0 | -2 | 1 | 1 |
| 30 Nov 15 | 0 | -2 | 1 | 1 |
| 31 Aug 15 | 0 | -2 | 1 | 1 |
| 31 May 15 | 0 | -1 | 1 | 0 |
| 28 Feb 15 | 0 | -1 | 1 | 0 |
| 30 Nov 14 | 0 | 0 | 0 | 0 |
| 31 Aug 14 | 0 | 0 | 0 | 0 |
| 31 May 14 | 0 | 0 | 0 | 0 |
| 28 Feb 14 | 0 | 0 | 0 | 0 |
| 30 Nov 13 | 0 | 0 | 0 | 0 |
Quality Earnings: CMXC is currently unprofitable.
Growing Profit Margin: CMXC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CMXC is unprofitable, but has reduced losses over the past 5 years at a rate of 20% per year.
Accelerating Growth: Unable to compare CMXC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CMXC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Return on Equity
High ROE: CMXC's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.